Deborah Mukherji· @dmukherji · X·· 2 天前评分70
正文 · 原文
Promising data in locally advanced penile cancer at #ESMO26!
Neoadjuvant toripalimab + TIP achieved 84% ORR and 48% pCR in a phase II study (n=25). @OncoAlert #HuiHan
148 浏览 · 2 赞 · 2 转发 · 0 回复
会议摘要
Neoadjuvant toripalimab combined with chemotherapy for locally advanced penile squamous cell carcinoma: A multicenter prospective, single-arm, phase II clinical trial
https://esmocongress.esmo.org来源：Deborah Mukherji · x.com